Education
About Us
Working with TipRanks
Follow Us
Anatara Lifesciences Ltd (AU:ANR)
ASX:ANR
RESEARCH TOOLSreports
Total Valuation
Anatara Lifesciences Ltd has a market cap or net worth of AU$1.28M. The enterprise value is ―.
Market CapAU$1.28M
Enterprise Value―
Share Statistics
Anatara Lifesciences Ltd has 213,383,730 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding213,383,730
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Anatara Lifesciences Ltd’s return on equity (ROE) is -1.06 and return on invested capital (ROIC) is -74.55%.
Return on Equity (ROE)-1.06
Return on Assets (ROA)-0.87
Return on Invested Capital (ROIC)-74.55%
Return on Capital Employed (ROCE)-1.07
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Anatara Lifesciences Ltd is -4.33. Anatara Lifesciences Ltd’s PEG ratio is 0.12.
PE Ratio-4.33
PS Ratio0.00
PB Ratio0.87
Price to Fair Value4.60
Price to FCF-0.69
Price to Operating Cash Flow-0.63
PEG Ratio0.12
Income Statement
In the last 12 months, Anatara Lifesciences Ltd had revenue of 0.00 and earned -1.45M in profits. Earnings per share was -0.01.
Revenue0.00
Gross Profit-748.91K
Operating Income-1.46M
Pretax Income-2.08M
Net Income-1.45M
EBITDA-1.46M
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was -1.86M and capital expenditures 0.00, giving a free cash flow of -1.86M billion.
Operating Cash Flow-1.86M
Free Cash Flow-1.86M
Free Cash Flow per Share>-0.01
Dividends & Yields
Anatara Lifesciences Ltd pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.35
52-Week Price Change-75.00%
50-Day Moving Average0.05
200-Day Moving Average0.05
Relative Strength Index (RSI)17.25
Average Volume (3m)1.06M
Important Dates
Anatara Lifesciences Ltd upcoming earnings date is Aug 20, 2025, TBA Not Confirmed.
Last Earnings DateFeb 24, 2025
Next Earnings DateAug 20, 2025
Ex-Dividend Date―
Financial Position
Anatara Lifesciences Ltd as a current ratio of 5.49, with Debt / Equity ratio of 0.00%
Current Ratio5.49
Quick Ratio5.49
Debt to Market Cap0.00
Net Debt to EBITDA0.67
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Anatara Lifesciences Ltd has paid -626.10K in taxes.
Income Tax-626.10K
Effective Tax Rate0.30
Enterprise Valuation
Anatara Lifesciences Ltd EV to EBITDA ratio is -3.64, with an EV/FCF ratio of -4.25.
EV to Sales0.00
EV to EBITDA-3.64
EV to Free Cash Flow-4.25
EV to Operating Cash Flow-4.25
Balance Sheet
Anatara Lifesciences Ltd has AU$1.10M in cash and marketable securities with AU$0.00 in debt, giving a net cash position of -AU$1.10M billion.
Cash & Marketable SecuritiesAU$1.10M
Total DebtAU$0.00
Net Cash-AU$1.10M
Net Cash Per Share>-AU$0.01
Tangible Book Value Per Share<AU$0.01
Margins
Gross margin is -428.52%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin-428.52%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Anatara Lifesciences Ltd is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast26.09%